SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-077250
Filing Date
2012-11-13
Accepted
2012-11-13 13:25:18
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20176_110q.htm 10-Q 986547
2 EX-31.1 a12-20176_1ex31d1.htm EX-31.1 10743
3 EX-31.2 a12-20176_1ex31d2.htm EX-31.2 10696
4 EX-32.1 a12-20176_1ex32d1.htm EX-32.1 7352
5 EX-32.2 a12-20176_1ex32d2.htm EX-32.2 7082
  Complete submission text file 0001104659-12-077250.txt   5325858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovas-20120930.xml EX-101.INS 533796
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20120930.xsd EX-101.SCH 52158
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20120930_cal.xml EX-101.CAL 50465
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20120930_def.xml EX-101.DEF 245698
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ovas-20120930_lab.xml EX-101.LAB 745656
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20120930_pre.xml EX-101.PRE 364508
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-902-0682
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54647 | Film No.: 121197678
SIC: 2835 In Vitro & In Vivo Diagnostic Substances